A carregar...
Augmentation of nab-paclitaxel chemotherapy response by mechanistically diverse antiangiogenic agents in preclinical gastric cancer models
Gastric adenocarcinoma (GAC) remains the third most common cause of cancer deaths worldwide. Systemic chemotherapy is commonly recommended as a fundamental treatment for metastatic GAC, however, standard treatment has not been established yet. Angiogenesis plays a crucial role in the progression and...
Na minha lista:
| Publicado no: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215503/ https://ncbi.nlm.nih.gov/pubmed/30166402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-0489 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|